Cellenkos

Cellenkos

Biotechnology, 5416 Chaucer Dr, Houston, Texas, 77005, United States, 11-50 Employees

cellenkosinc.com

  • LinkedIn

phone no Phone Number: 83********

Who is CELLENKOS

Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory d...

Read More

map
  • 5416 Chaucer Dr, Houston, Texas, 77005, United States Headquarters: 5416 Chaucer Dr, Houston, Texas, 77005, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CELLENKOS

Cellenkos Org Chart and Mapping

Employees

Rachelle Espinosa

Clinical Manufacturing Manager

Claudia Garza-Gonzalez

Clinical Manufacturing QA and Regulatory Manager

Monica Avila

Senior Director-CMC Alliance and Project Management

Sarah Champlin

Manager of Quality Control and Materials Management

Hadley Flessner

Administrative Consultant

Charisse Ayuste

Process Development and Marketing

Tara Sadeghi

Chief Operating Officer

Megan Abella

Administrative Assistant

Aurash Javidinejad

Clinical Trial Management System & Data Systems Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cellenkos

Answer: Cellenkos's headquarters are located at 5416 Chaucer Dr, Houston, Texas, 77005, United States

Answer: Cellenkos's phone number is 83********

Answer: Cellenkos's official website is https://cellenkosinc.com

Answer: Cellenkos's revenue is $1 Million to $5 Million

Answer: Cellenkos's SIC: 2834

Answer: Cellenkos's NAICS: 325412

Answer: Cellenkos has 11-50 employees

Answer: Cellenkos is in Biotechnology

Answer: Cellenkos contact info: Phone number: 83******** Website: https://cellenkosinc.com

Answer: Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access